首頁 > 市場調查報告書 > 製藥

神經疾病

癲癇市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按類型、給藥途徑、治療類型、年齡層、配銷通路和地理位置

市場調查報告書

商品編碼

1450838

癲癇市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按類型、給藥途徑、治療類型、年齡層、配銷通路和地理位置

Epilepsy Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Route of Administration, Treatment Type, Age Group, Distribution Channel, and Geography

出版日期: 2024年02月14日 | 出版商:

The Insight Partners | 英文 230 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

癲癇市場規模預計將從2022年的77億美元成長到2030年的107億美元；預計 2022 年至 2030 年CAGR為 4.1%。

癲癇是世界上最常見的慢性神經系統疾病之一。這種疾病與大腦異常電活動有關，影響超過 100 萬美國育齡婦女。癲癇盛行率的上升和癲癇療法開發投資的增加是導致癲癇市場擴大的重要因素。抗癲癇藥物（AED）的施用通常被稱為癲癇的一線治療。約80%的癲癇患者來自發展中國家。無論是兒童或成人，癲癇的治療大多是基於藥物的使用（單一療法或合併療法），而其餘的治療方法，如手術、神經調節和生酮飲食，使用頻率較低。然而，產品召回阻礙了癲癇市場的成長。

基於年齡層的見解

根據年齡層，癲癇市場分為成人和兒童。 2022 年，成人細分市場將佔據更大的癲癇市場。預計 2022-2030 年市場CAGR將更高。成人更容易患癲癇，因為這種疾病的一些危險因素在成人中更常見；這些疾病包括影響大腦功能的疾病（例如阿茲海默症）、腦腫瘤、中風和頭部受傷。根據美國疾病管制與預防中心 (CDC) 的數據，美國有 300 萬 18 歲或以上的成年人患有活動性癲癇症。其中近 100 萬成年人年齡在 55 歲或以上。隨著人口老化，未來幾年可能會有更多老年人患有癲癇。 2021 年，1.1% 的美國成年人（約 286 萬名成年人）報告患有活動性癲癇。因此，藥物和治療策略通常優先考慮成年患者，與該年齡層癲癇的人口盛行率保持一致。

基於最終用戶的見解

根據配銷通路，癲癇市場分為醫院藥房、零售藥房等。醫院藥局細分市場在 2022 年佔據最大的癲癇市場佔有率。此外，零售藥局細分市場預計在 2022 年至 2030 年期間將實現最高的CAGR。零售藥局銷售處方藥、非處方藥和一些快速消費品，並提供相關服務。現代零售藥房連鎖店是數位化、組織化和技術支援的，這使他們能夠追蹤藥品庫存並銷售 100% 可靠的商品。此外，零售藥局連鎖店也為選擇醫療索賠或保險申報的消費者提供加值服務。他們還可以被要求翻新以前的帳單或備忘錄。此外，它們的位置使患者可以方便地配藥並接受藥劑師的諮詢。

疾病管制與預防中心、世界衛生組織和加拿大神經健康慈善機構是準備癲癇市場報告時參考的主要和次要來源。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
- 亞太地區其他地區
中東和非洲
- 中東和非洲
  - 沙烏地阿拉伯
  - 南非
  - 阿拉伯聯合大公國
  - 中東和非洲其他地區
  - 中東和非洲其他地區
南美洲和中美洲
- 南美洲和中美洲
  - 巴西
  - 阿根廷
  - 南美洲和中美洲其他地區
  - 南美洲和中美洲其他地區

第 13 章：產業格局

概述
癲癇市場的成長策略
有機成長策略
- 概述
無機成長策略
- 概述

第 14 章：公司簡介

Abbott Laboratories
Pfizer Inc
Eisai Co Ltd
UCB SA
CombiGene AB
LivaNova Plc
Novartis AG
Medtronic Plc
GSK Plc
H. Lundbeck AS

第 15 章：附錄

簡介目錄圖表

Product Code: TIPRE00016405

The epilepsy market size is expected to grow from US$ 7.7 billion in 2022 to US$ 10.7 billion by 2030; it is projected to register a CAGR of 4.1% during 2022-2030.

Epilepsy is one of the most common chronic neurological disorders across the world. Associated with an abnormal electrical activity in the brain, this disorder affects over 1 million American women of childbearing age. The rising prevalence of epilepsy and increasing investments in the development of epilepsy therapies are noteworthy factors contributing to the expansion of the epilepsy market size. The administration of anti-epileptic drugs (AEDs) is usually referred to as the first-line treatment for epilepsy. Approximately 80% of the people suffering from epilepsy are from developing countries. In children as well as adults, the treatment of epilepsy is mostly based on the use of drugs (either in monotherapy or combined therapy), while the remaining treatment approaches, such as surgery, neuromodulation, and ketogenic diet, are used at a lesser frequency. However, the recall of products hinders the epilepsy market growth.

Age Group-Based Insights

Based on age group, the epilepsy market is segmented into adults and children. The adults segment held a larger epilepsy market share in 2022. It is further expected to register a higher CAGR in the market during 2022-2030. Epilepsy is more likely to develop in adults as some risk factors for this disease are more common in adults; these include diseases affecting brain function (such as Alzheimer's disease), brain tumors, strokes, and head injuries. According to the Centers for Disease Control and Prevention (CDC), 3 million adults aged 18 or older are living with active epilepsy in the US. Nearly 1 million of these adults are aged 55 or older. As the population ages, even more older people are likely to suffer from epilepsy in the coming years. In 2021, 1.1% of US adults (~2.86 million adults) reported active epilepsy. Thus, medications and treatment strategies often prioritize adult patients, aligning with the demographic prevalence of epilepsy in this age group.

End User-Based Insights

Based on distribution channel, the epilepsy market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest epilepsy market share in 2022. In addition, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022-2030. Retail pharmacy stores sell prescription drugs, over-the-counter drugs, and some fast-moving consumer goods, along with providing related services. Modern retail pharmacy chains are digitized, organized, and tech-enabled, which allows them to track medication inventories and sell 100% reliable goods. In addition, retail pharmacy chains provide value-added services for consumers opting for medical claims or insurance filings. They can also be requested to refurbish previous bills or memos. Moreover, their locations make them accessible for patients to fill their prescriptions and receive counseling from pharmacists.

Centers for Disease Control and Prevention, the World Health Organization, and Neurological Health Charities Canada are among the primary and secondary sources referred to while preparing the epilepsy market report.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Epilepsy Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Epilepsy Market - Key Market Dynamics

5.1 Epilepsy Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Epilepsy
- 5.2.2 Increasing Investments in Development of Epilepsy Therapies
5.3 Market Restraints
- 5.3.1 Recall of Products
5.4 Market Opportunities
- 5.4.1 Surge in Awareness Programs Conducted by Organizations
5.5 Future Trends
- 5.5.1 Gene Therapy as Promising Treatment Approach
5.6 Impact of Drivers and Restraints:

6. Epilepsy Market - Global Market Analysis

6.1 Epilepsy Market Revenue (US$ Million), 2022-2030

7. Epilepsy Market Analysis - by Type

7.1 Overview
7.2 Progressive Myoclonic Epilepsy
- 7.2.1 Overview
- 7.2.2 Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Reflex Epilepsy
- 7.3.1 Overview
- 7.3.2 Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Generalized Epilepsy
- 7.4.1 Overview
- 7.4.2 Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Other
- 7.5.1 Overview
- 7.5.2 Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

8. Epilepsy Market Analysis - by Route of Administration

8.1 Overview
8.2 Oral
- 8.2.1 Overview
- 8.2.2 Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Parenteral
- 8.3.1 Overview
- 8.3.2 Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

9. Epilepsy Market Analysis - by Treatment Type

9.1 Overview
9.2 First Generation Drugs
- 9.2.1 Overview
- 9.2.2 First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Second Generation Drugs
- 9.3.1 Overview
- 9.3.2 Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Third Generation Drugs
- 9.4.1 Overview
- 9.4.2 Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

10. Epilepsy Market Analysis - by Age Group

10.1 Overview
10.2 Adult
- 10.2.1 Overview
- 10.2.2 Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Children
- 10.3.1 Overview
- 10.3.2 Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

11. Epilepsy Market Analysis - by Distribution Channel

11.1 Overview
11.2 Hospital Pharmacies
- 11.2.1 Overview
- 11.2.2 Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
11.3 Retail Pharmacies
- 11.3.1 Overview
- 11.3.2 Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)

12. Epilepsy Market - Geographical Analysis

12.1 North America: Epilepsy Market
- 12.1.1 Overview
- 12.1.2 North America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  - 12.1.2.1 North America: Epilepsy Market - Revenue and Forecast Analysis - by Type
  - 12.1.2.2 North America: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
  - 12.1.2.3 North America: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
  - 12.1.2.4 North America: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
  - 12.1.2.5 North America: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.1.3 North America: Epilepsy Market - Revenue and Forecast Analysis - by Country
  - 12.1.3.1 United States: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.1.1 Overview
    - 12.1.3.1.2 United States: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.1.3 United States: Epilepsy Market Breakdown, by Type
    - 12.1.3.1.4 United States: Epilepsy Market Breakdown, by Route of Administration
    - 12.1.3.1.5 United States: Epilepsy Market Breakdown, by Treatment Type
    - 12.1.3.1.6 United States: Epilepsy Market Breakdown, by Age Group
    - 12.1.3.1.7 United States: Epilepsy Market Breakdown, by Distribution Channel
  - 12.1.3.2 Canada: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.2.1 Overview
  - 12.1.3.3 Canada: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.3.1 Canada: Epilepsy Market Breakdown, by Type
    - 12.1.3.3.2 Canada: Epilepsy Market Breakdown, by Route of Administration
    - 12.1.3.3.3 Canada: Epilepsy Market Breakdown, by Treatment Type
    - 12.1.3.3.4 Canada: Epilepsy Market Breakdown, by Age Group
    - 12.1.3.3.5 Canada: Epilepsy Market Breakdown, by Distribution Channel
  - 12.1.3.4 Mexico: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.4.1 Overview
  - 12.1.3.5 Mexico: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.3.5.1 Mexico: Epilepsy Market Breakdown, by Type
    - 12.1.3.5.2 Mexico: Epilepsy Market Breakdown, by Route of Administration
    - 12.1.3.5.3 Mexico: Epilepsy Market Breakdown, by Treatment Type
    - 12.1.3.5.4 Mexico: Epilepsy Market Breakdown, by Age Group
    - 12.1.3.5.5 Mexico: Epilepsy Market Breakdown, by Distribution Channel
12.2 Europe: Epilepsy Market
- 12.2.1 Overview
- 12.2.2 Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  - 12.2.2.1 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Type
  - 12.2.2.2 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
  - 12.2.2.3 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
  - 12.2.2.4 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
  - 12.2.2.5 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.2.3 Europe: Epilepsy Market - Revenue and Forecast Analysis - by Country
  - 12.2.3.1 United Kingdom: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.1.1 Overview
  - 12.2.3.2 United Kingdom: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.2.1 United Kingdom: Epilepsy Market Breakdown, by Type
    - 12.2.3.2.2 United Kingdom: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.2.3 United Kingdom: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.2.4 United Kingdom: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.2.5 United Kingdom: Epilepsy Market Breakdown, by Distribution Channel
  - 12.2.3.3 Germany: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.3.1 Overview
  - 12.2.3.4 Germany: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.4.1 Germany: Epilepsy Market Breakdown, by Type
    - 12.2.3.4.2 Germany: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.4.3 Germany: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.4.4 Germany: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.4.5 Germany: Epilepsy Market Breakdown, by Distribution Channel
  - 12.2.3.5 France: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.5.1 Overview
  - 12.2.3.6 France: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.6.1 France: Epilepsy Market Breakdown, by Type
    - 12.2.3.6.2 France: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.6.3 France: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.6.4 France: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.6.5 France: Epilepsy Market Breakdown, by Distribution Channel
  - 12.2.3.7 Spain: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.7.1 Overview
  - 12.2.3.8 Spain: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.8.1 Spain: Epilepsy Market Breakdown, by Type
    - 12.2.3.8.2 Spain: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.8.3 Spain: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.8.4 Spain: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.8.5 Spain: Epilepsy Market Breakdown, by Distribution Channel
  - 12.2.3.9 Italy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.9.1 Overview
  - 12.2.3.10 Italy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.10.1 Italy: Epilepsy Market Breakdown, by Type
    - 12.2.3.10.2 Italy: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.10.3 Italy: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.10.4 Italy: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.10.5 Italy: Epilepsy Market Breakdown, by Distribution Channel
  - 12.2.3.11 Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.11.1 Overview
  - 12.2.3.12 Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.2.3.12.1 Rest of Europe: Epilepsy Market Breakdown, by Type
    - 12.2.3.12.2 Rest of Europe: Epilepsy Market Breakdown, by Route of Administration
    - 12.2.3.12.3 Rest of Europe: Epilepsy Market Breakdown, by Treatment Type
    - 12.2.3.12.4 Rest of Europe: Epilepsy Market Breakdown, by Age Group
    - 12.2.3.12.5 Rest of Europe: Epilepsy Market Breakdown, by Distribution Channel
12.3 Asia Pacific: Epilepsy Market
- 12.3.1 Overview
- 12.3.2 Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  - 12.3.2.1 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Type
  - 12.3.2.2 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
  - 12.3.2.3 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
  - 12.3.2.4 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
  - 12.3.2.5 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.3.3 Asia Pacific: Epilepsy Market - Revenue and Forecast Analysis - by Country
  - 12.3.3.1 China: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.1.1 Overview
  - 12.3.3.2 China: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.2.1 China: Epilepsy Market Breakdown, by Type
    - 12.3.3.2.2 China: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.2.3 China: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.2.4 China: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.2.5 China: Epilepsy Market Breakdown, by Distribution Channel
  - 12.3.3.3 Japan: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.3.1 Overview
  - 12.3.3.4 Japan: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.4.1 Japan: Epilepsy Market Breakdown, by Type
    - 12.3.3.4.2 Japan: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.4.3 Japan: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.4.4 Japan: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.4.5 Japan: Epilepsy Market Breakdown, by Distribution Channel
  - 12.3.3.5 India: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.5.1 Overview
  - 12.3.3.6 India: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.6.1 India: Epilepsy Market Breakdown, by Type
    - 12.3.3.6.2 India: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.6.3 India: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.6.4 India: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.6.5 India: Epilepsy Market Breakdown, by Distribution Channel
  - 12.3.3.7 Australia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.7.1 Overview
  - 12.3.3.8 Australia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.8.1 Australia: Epilepsy Market Breakdown, by Type
    - 12.3.3.8.2 Australia: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.8.3 Australia: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.8.4 Australia: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.8.5 Australia: Epilepsy Market Breakdown, by Distribution Channel
  - 12.3.3.9 South Korea: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.9.1 Overview
  - 12.3.3.10 South Korea: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.10.1 South Korea: Epilepsy Market Breakdown, by Type
    - 12.3.3.10.2 South Korea: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.10.3 South Korea: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.10.4 South Korea: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.10.5 South Korea: Epilepsy Market Breakdown, by Distribution Channel
  - 12.3.3.11 Rest of Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.11.1 Overview
  - 12.3.3.12 Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.3.3.12.1 Rest of APAC: Epilepsy Market Breakdown, by Type
    - 12.3.3.12.2 Rest of APAC: Epilepsy Market Breakdown, by Route of Administration
    - 12.3.3.12.3 Rest of APAC: Epilepsy Market Breakdown, by Treatment Type
    - 12.3.3.12.4 Rest of APAC: Epilepsy Market Breakdown, by Age Group
    - 12.3.3.12.5 Rest of APAC: Epilepsy Market Breakdown, by Distribution Channel
12.4 Middle East & Africa Epilepsy Market
- 12.4.1 Overview
- 12.4.2 Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  - 12.4.2.1 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Type
  - 12.4.2.2 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
  - 12.4.2.3 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
  - 12.4.2.4 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
  - 12.4.2.5 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.4.3 Middle East and Africa: Epilepsy Market - Revenue and Forecast Analysis - by Country
  - 12.4.3.1 Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.1.1 Overview
  - 12.4.3.2 Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.2.1 Saudi Arabia: Epilepsy Market Breakdown, by Type
    - 12.4.3.2.2 Saudi Arabia: Epilepsy Market Breakdown, by Route of Administration
    - 12.4.3.2.3 Saudi Arabia: Epilepsy Market Breakdown, by Treatment Type
    - 12.4.3.2.4 Saudi Arabia: Epilepsy Market Breakdown, by Age Group
    - 12.4.3.2.5 Saudi Arabia: Epilepsy Market Breakdown, by Distribution Channel
  - 12.4.3.3 South Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.3.1 Overview
  - 12.4.3.4 South Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.4.1 South Africa: Epilepsy Market Breakdown, by Type
    - 12.4.3.4.2 South Africa: Epilepsy Market Breakdown, by Route of Administration
    - 12.4.3.4.3 South Africa: Epilepsy Market Breakdown, by Treatment Type
    - 12.4.3.4.4 South Africa: Epilepsy Market Breakdown, by Age Group
    - 12.4.3.4.5 South Africa: Epilepsy Market Breakdown, by Distribution Channel
  - 12.4.3.5 United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.5.1 Overview
  - 12.4.3.6 United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.6.1 United Arab Emirates: Epilepsy Market Breakdown, by Type
    - 12.4.3.6.2 United Arab Emirates: Epilepsy Market Breakdown, by Route of Administration
    - 12.4.3.6.3 United Arab Emirates: Epilepsy Market Breakdown, by Treatment Type
    - 12.4.3.6.4 United Arab Emirates: Epilepsy Market Breakdown, by Age Group
    - 12.4.3.6.5 United Arab Emirates: Epilepsy Market Breakdown, by Distribution Channel
  - 12.4.3.7 Rest of Middle East & Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.7.1 Overview
  - 12.4.3.8 Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.4.3.8.1 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Type
    - 12.4.3.8.2 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Route of Administration
    - 12.4.3.8.3 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Treatment Type
    - 12.4.3.8.4 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Age Group
    - 12.4.3.8.5 Rest of Middle East and Africa: Epilepsy Market Breakdown, by Distribution Channel
12.5 South & Central America: Epilepsy Market
- 12.5.1 Overview
- 12.5.2 South and Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
  - 12.5.2.1 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Type
  - 12.5.2.2 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Route of Administration
  - 12.5.2.3 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Treatment Type
  - 12.5.2.4 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Age Group
  - 12.5.2.5 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Distribution Channel
- 12.5.3 South and Central America: Epilepsy Market - Revenue and Forecast Analysis - by Country
  - 12.5.3.1 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.1.1 Overview
  - 12.5.3.2 Brazil: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.2.1 Brazil: Epilepsy Market Breakdown, by Type
    - 12.5.3.2.2 Brazil: Epilepsy Market Breakdown, by Route of Administration
    - 12.5.3.2.3 Brazil: Epilepsy Market Breakdown, by Treatment Type
    - 12.5.3.2.4 Brazil: Epilepsy Market Breakdown, by Age Group
    - 12.5.3.2.5 Brazil: Epilepsy Market Breakdown, by Distribution Channel
  - 12.5.3.3 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.3.1 Overview
  - 12.5.3.4 Argentina: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.4.1 Argentina: Epilepsy Market Breakdown, by Type
    - 12.5.3.4.2 Argentina: Epilepsy Market Breakdown, by Route of Administration
    - 12.5.3.4.3 Argentina: Epilepsy Market Breakdown, by Treatment Type
    - 12.5.3.4.4 Argentina: Epilepsy Market Breakdown, by Age Group
    - 12.5.3.4.5 Argentina: Epilepsy Market Breakdown, by Distribution Channel
  - 12.5.3.5 Rest of South & Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.5.1 Overview
  - 12.5.3.6 Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.5.3.6.1 Rest of South and Central America: Epilepsy Market Breakdown, by Type
    - 12.5.3.6.2 Rest of South and Central America: Epilepsy Market Breakdown, by Route of Administration
    - 12.5.3.6.3 Rest of South and Central America: Epilepsy Market Breakdown, by Treatment Type
    - 12.5.3.6.4 Rest of South and Central America: Epilepsy Market Breakdown, by Age Group
    - 12.5.3.6.5 Rest of South and Central America: Epilepsy Market Breakdown, by Distribution Channel

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in Epilepsy Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Pfizer Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Eisai Co Ltd
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 UCB SA
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 CombiGene AB
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 LivaNova Plc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Novartis AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Medtronic Plc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 GSK Plc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 H. Lundbeck AS
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

簡介目錄圖表

List Of Tables

Table 1. Epilepsy Market Segmentation
Table 2. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 3. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 4. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 5. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 6. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 7. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 8. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 9. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 10. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 11. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 12. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 13. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 14. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 15. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 16. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 17. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 18. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 19. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 20. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 21. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 22. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 23. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 24. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 25. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 26. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 27. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 28. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 29. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 30. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 31. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 32. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 33. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 34. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 35. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 36. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 37. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 38. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 39. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 40. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 41. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 42. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 43. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 44. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 45. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 46. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 47. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 48. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 49. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 50. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 51. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 52. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 53. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 54. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 55. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 56. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 57. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 58. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 59. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 60. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 61. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 62. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 63. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 64. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 65. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 66. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 67. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 68. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 69. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 70. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 71. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 72. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 73. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 74. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 75. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 76. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 77. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 78. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 79. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 80. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 81. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 82. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 83. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 84. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 85. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 86. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 87. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 88. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 89. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 90. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 91. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 92. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 93. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 94. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 95. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 96. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 97. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 98. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 99. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 100. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 101. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 102. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 103. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 104. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 105. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 106. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 107. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 108. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 109. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 110. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 111. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 112. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 113. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 114. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 115. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 116. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 117. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 118. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 119. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 120. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 121. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 122. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 123. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 124. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 125. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 126. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 127. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 128. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 129. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 130. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 131. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 132. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 133. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Route of Administration
Table 134. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Treatment Type
Table 135. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Age Group
Table 136. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 137. Recent Organic Growth Strategies in Epilepsy Market
Table 138. Recent Inorganic Growth Strategies in the Epilepsy Market

List Of Figures

Figure 1. Epilepsy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Epilepsy Market Revenue (US$ Million), 2022-2030
Figure 5. Epilepsy Market Revenue, Geography (US$ Mn), 2022 - 2030
Figure 6. Epilepsy Market Share (%) - by Type (2022 and 2030)
Figure 7. Progressive Myoclonic Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Reflex Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Generalized Epilepsy: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Other: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Epilepsy Market Share (%) - by Route of Administration (2022 and 2030)
Figure 12. Oral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Parenteral: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy Market Share (%) - by Treatment Type (2022 and 2030)
Figure 16. First Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Second Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Third Generation Drugs: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Epilepsy Market Share (%) - by Age Group (2022 and 2030)
Figure 20. Adult: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Children: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Epilepsy Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 23. Hospital Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Retail Pharmacies: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. North America: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 27. North America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. North America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 29. United States: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Canada: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Mexico: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Europe: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 33. Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Europe: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 35. United Kingdom: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Germany: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. France: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Spain: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Italy: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 40. Rest of Europe: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 41. Asia Pacific: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 42. Asia Pacific: Epilepsy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 43. Asia Pacific: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 44. China: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 45. Japan: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 46. India: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 47. Australia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 48. South Korea: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 49. Rest of APAC: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 50. Middle East & Africa: Epilepsy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 51. Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 52. Middle East and Africa: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. Saudi Arabia: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 54. South Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 55. United Arab Emirates: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 56. Rest of Middle East and Africa: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 57. South & Central America: Epilepsy Market, By Key Country - Revenue (2022) (US$ Million)
Figure 58. South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 59. South and Central America: Epilepsy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 60. Brazil: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 61. Argentina: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 62. Rest of South and Central America: Epilepsy Market - Revenue and Forecast to 2030(US$ Million)
Figure 63. Growth Strategies in Epilepsy Market